Treatment with non selective beta blockers is associated with reduced severity of system inflamation and improved survival of patients with acute on chronic liver failure

Ver

Non invasive assessment of portal hypertension using quantitative magnetic resonance imaging

Ver

Neuroendocrine neuroplasms of the liver: a 5 year retrospective study applying World Health Organization 2010 clasification

Ver

von Willebrand factor and procoagulant imbalance independently predict outcome in patients with cirrhosis

Ver

Response guided peginterferon therapy in patientswith HBeAg positive chronic hepatitis B: A randomized controlled study

Ver

Time to descompensated cirrhosis and hepatocelullar carcinoma after an HBV or HCV notification

Ver

Y90 radioembolization significantly prolongs time to progression compared with chemoembolization in patients with hepatocellular carcinoma

Ver

Ursodeoxycholic acid in advanced polycystic liver disease: a phase 2 multicenter randomiced controlled trial

Ver

Risk factors for cholangiocarcinoma: aspirin use and the risk of cholangiocarcinoma

Ver

Survival benefit of liver resection for hepatocellular carcinoma associated with portal vein invasion

Ver

Plasma copeptin is a biomarker of disease progression and prognosis in cirrhosis

Ver

Unexpected early tumor recurrence in patients with hepatitis C virus- related hepatocellular carcinoma undergoing interferon free therapy: a note of caution

Ver

Tenofovir to prevent hepatitis B transmission in mothers with high viral loads

Ver

Testosterone therapy increases muscle mass in cirrhitic patients and low testosterone: a randomised controlled trial

Ver

Treatment with non seletive beta blockers is associated with reduced severity of sistemic inflammation and improved survival of patients with acute on chronic liver failure

Ver

Validation of transient elastography in autoinmunne hepatitis: timing determines the impact of inflamation and fibrosis

Ver

Addition of simvastatin ti standard therapy for the prevention of variceal rebleeding does not reduce rebleeding but increases survivak in patients with cirrhosis

Ver

Alkaline phosphatase normalization is a biomarker of improved survival in primary sclerosing cholangitis

Ver

Correlation between serum cytokeratin-18 and the pregression or regression of non alcoholic fatty liver disease

Ver

Intensive enteral nutrition is ineffective for patients with severe alcoholic hepatitis treated with corticosteroids

Ver

Validation of transient elastography in autoinmune hepatitis: timing determine the impact of inflamation and fibrosis

Ver

 

 

 

 

 

2016 - 2015 - 2014 - 2013 -2012 -2011 -2010 - 2009

 

 
 

 

 

Dirección: Urquiza 3100, Rosario (2000), Santa Fe, Argentina
e-mail: contactohepagastro@gmail.com
TEL: 0341-4393511

Diseño web IDEAS MED | Tabone Juan Pablo | www.ideasmed.com.ar |

Hepagastro | Dr. Federico Tanno | Todos los derechos reservados 2015.-